HRA005369
Title:
Biomarker exploration for immunochemotherapy as first-line treatment in advanced biliary tract cancer
Release date:
2024-01-15
Description:
In this study, 125 patients with advanced biliary tract cancer who received immunotherapy plus chemotherapy as first-line treatment were enrolled. Tumor samples before first-line immunochemotherapy were conducted targeted-NGS and RNA sequencing. Biomarkers related to response and PFS/OS were explored.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
Biliary tract cancer
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
BTC_IO_DAC
Contact person:
Ying Jieer
Email:
yingje@zjcc.org.cn
Description:
This DAC has 3 members and responsible for the data control and management.
Individuals & samples
Submitter:   Ying Jieer / yingje@zjcc.org.cn
Organization:   Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences
Submission date:   2023-08-21
Requests:   2